DPP4 and gallbladder disorder: However, there was no association between using DPP-4 inhibitors and bile duct and gallbladder diseases compared with current use of at least two oral antidiabetic drugs (3.6 vs. 3.3 per 1000 person-years; adjusted HR, 0.99; 95% CI, 0.75–1.32).